High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: A randomised controlled trial

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Amadi, Beatrice ^a   Mwiya, Mwiya ^a   Sianongo, Sandie ^a   Payne, Lara ^a   Watuka, Angela ^a   Katubulushi, Max ^a   Kelly, Paul ^a,b  

^a UNIVERSITY OF ZAMBIA   (Zambia)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITAZOXANIDE; PLACEBO; ANTIPARASITIC AGENT; THIAZOLE DERIVATIVE;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SCLERA DISCOLORATION; SCLERA DISEASE; TREATMENT DURATION; VOMITING; INFANT; PRESCHOOL CHILD; TREATMENT OUTCOME; ZAMBIA;

ANTIPARASITIC AGENTS; CHILD, PRESCHOOL; CRYPTOSPORIDIOSIS; DOUBLE-BLIND METHOD; FEMALE; HIV SEROPOSITIVITY; HUMANS; INFANT; MALE; THIAZOLES; TREATMENT OUTCOME; ZAMBIA;

EID: 73149102077     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-195     Document Type: Article

References (16)

1. Mølbak K, Andersen M, Aaby P, Højlyng N, Jakobsen M, Sodemann M, da Silva AP. Cryptosporidium infection in infancy as a cause of malnutrition: a community study from Guinea-Bissau, West Africa. Am J Clin Nutr 1997, 65:149-52.
2. Amadi BC, Kelly P, Mwiya M, Mulwazi E, Sianongo S, Changwe F, Thomson M, Hachungula J, Watuka A, Walker-Smith JA, Chintu C. Intestinal and systemic infection, HIV and mortality in Zambian children with persistent diarrhoea and malnutrition. J Ped Gast Nutr 2001, 32:550-554.
3. Nchito M, Kelly P, Sianongo S, Luo NP, Feldman RA, Farthing MJG, Baboo KS. Cryptosporidiosis in urban Zambian children: an analysis of risk factors. Am J Trop Hyg 1998, 59:435-437.
4. Guerrant DI, Moore SR, Lima AA, Patrick PD, Schorling JB, Guerrant RL. Association of early childhood diarrhoea and cryptosporidiosis with impaired physical fitness and cognitive function 4-7 years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg 1999, 61:707-13.
5. White AC. Nitazoxanide: an important advance in anti-parasitic therapy. Am J Trop Med Hyg 2003, 68:382-3.
6. Abubakar I, Aliyu SH, Arumugam C, Usman NK, Hunter PR. Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis. Br J Clin Pharmacol 2007, 63:387-93. 10.1111/j.1365-2125.2007.02873.x, 2203234, 17335543.
7. Abubakar I, Aliyu SH, Arumugam C, Hunter PR, Usman NK. Prevention and treatment of cryptosporidiosis in immunocompromised patients. Cochrane Database Syst Rev 2007, 24(1):CD004932.
8. Amadi BC, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub A, Kelly P. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 2002, 360:1375-1380. 10.1016/S0140-6736(02)11401-2, 12423984.
9. Mor SM, Tzipori S. Cryptosporidiosis in children in sub-Saharan Africa: a lingering challenge. Clin Infect Dis 2008, 47:915-921. 10.1086/591539, 2724762, 18715159.
10. Zulu I, Kelly P, Njobvu L, Sianongo S, Kaonga K, McDonald V, Farthing M, Pollok R. Nitazoxanide for persistent diarrhoea in Zambian AIDS patients: a randomized controlled trial. Aliment Pharmacol Therap 2005, 21:757-763.
11. Rossignol JF. Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients. Aliment Pharmacol Ther 2006, 24:887-94. 10.1111/j.1365-2036.2006.03033.x, 16918894.
12. Rossignol JF, Hidalgo H, Feregrino M, Higuera F, Gomez WH, Romero JL, Padierna J, Geyne A, Ayers MS. A double-blind placebo controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans R Soc Trop Med Hyg 1998, 92:663-6. 10.1016/S0035-9203(98)90804-5, 10326116.
13. Fox LM, Saravolatz LD. Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis 2005, 40:1173-1180. 10.1086/428839, 15791519.
14. Lim SG, Condez A, Lee CA, Johnson MA, Elia C, Poulter LW. Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol 1993, 92:448-454. 1554790, 8099858.
15. Schneider T, Jahn HU, Schmidt W, Riecken EO, Zeitz M, Ullrich R. Loss of CD4 lymphocytes in patients infected with HIV type 1 is more pronounced in the duodenal mucosa than in peripheral blood. Gut 1995, 37:524-529. 10.1136/gut.37.4.524, 1382905, 7489940.
16. Wang X, Rasmussen T, Pahar B, Poonia B, Alvarez X, Lackner AA, Veazey RS. Massive infection and loss of CD4+ T cells occurs in the intestinal tract of neonatal rhesus macaques in acute SIV infection. Blood 2007, 109:1174-1181. 10.1182/blood-2006-04-015172, 1785148, 17047153.